2 employees
Tiaki Therapeutics is committed to developing microglia-targeted therapeutics for the treatment of dementias.
2017
TIAKI THERAPEUTICS raised undisclosed on January 1, 2018
Investors: Dolby Family Ventures and The Dementia Discovery Fund